What drove the pre-market move in MED.SW stock on 11 Mar 2026?

The pre-market move (+5.98% to CHF85.10) was driven by earnings positioning ahead of the 17 Mar 2026 report and short-term buying. Volume was **3,279.00** versus an average **4,928.00**, indicating active but below-average trade intensity.

What is Meyka AI’s view and grade on MED.SW stock?

Meyka AI rates MED.SW **73.75 / 100**, Grade **B+**, Suggestion: **BUY**. The grade factors in benchmark comparisons, sector performance, growth, key metrics, and forecasts. This is informational, not financial advice.

What price target or forecast should investors watch for MED.SW stock?

Meyka AI's forecast model lists a quarterly projection of **CHF98.37**, implying **+15.59%** versus the current **CHF85.10**. The yearly model is **CHF83.63**, implying modest downside. Forecasts are model-based and not guarantees.

What are the main risks for MED.SW stock ahead of earnings?

Key risks include an EPS near **-0.05**, very high inventory days (**641.96**), thin interest coverage (**0.98**), and sensitivity to surgical-device demand. Any weak guidance could pressure the price on SIX.

CH Stocks

MED.SW up 5.98% to CHF85.10 pre-market on SIX 11 Mar 2026: Watch 17 Mar earnings

ByDanny Kontos March 11, 2026March 11, 2026

The MED.SW stock jumped 5.98% to CHF85.10 in pre-market trading on the SIX on 11 Mar 2026, making it a high-volume mover to watch. Trading accelerated ahead of an earnings announcement on 17 Mar 2026, with volume at 3,279.00 shares versus an average of 4,928.00. We see this move driven by short-term traders and position adjustments ahead of results. This article breaks down price action, valuation, technical signals, the upcoming catalyst, and Meyka AI’s grade and forecast for Medartis Holding AG (MED.SW stock) on the SIX in Switzerland.